You just read:

EnGeneIC Ltd. to Initiate U.S. Phase 1 Clinical Study Using Targeted EDV™ Nanocells to Treat Advanced Glioma Patients

News provided by

EnGeneIC Ltd.

Sep 16, 2015, 09:23 ET